Similar Articles
1201 Feasibility and safety of sorafenib treatment in hepatocellular carcinoma patients with spontaneous rupture
1202 Metformin does not improve survival in patients with hepatocellular carcinoma
1203 Pathogenesis, prevention, diagnosis and management of retinal vein occlusion
1204 Current surgical treatment strategies for hepatocellular carcinoma in North America
1205 Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma
1206 Safety of hepatectomy for elderly patients with hepatocellular carcinoma
1207 Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
1208 Risk factor analysis of perioperative mortality after ruptured bleeding in hepatocellular carcinoma
1209 Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives
1210 Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA